Skip to content
Stop using now Drug recall · FDA · Published December 29, 2015

Recall: Complete Pharmacy HCG Syringes Due to Mold Hazard

Complete Pharmacy recalls 1,890 syringes of Human Chorionic Gonadotropin due to confirmed mold. Check lot #2079ps5.

🇺🇸 FDA recall #D-0917-2017DrugComplete Pharmacy & Medical Solutions ›
Take action

Contact the company

Recalling firmComplete Pharmacy and Medical Solutions LLC5829 Nw 158th St · Miami Lakes, FL 33014-6721
✎ GovInfoNow plain-language explainer

What happened, in plain English

Complete Pharmacy and Medical Solutions LLC is recalling Human Chorionic Gonadotropin (HCG) in 0.5 ml syringes because the product was found to be non-sterile. An outside laboratory confirmed the presence of mold during a 14-day culture test. This recall affects 1,890 syringes distributed throughout Florida. Read more at govinfonow.com/recall/43302-recall-complete-pharmacy-hcg-syringes-due-to-mold-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/43302-recall-complete-pharmacy-hcg-syringes-due-to-mold-hazard · Updated October 11, 2026 · FDA enforcement record: FDA #D-0917-2017

Cite this page

“Recall: Complete Pharmacy HCG Syringes Due to Mold Hazard.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43302-recall-complete-pharmacy-hcg-syringes-due-to-mold-hazard. Based on FDA recall #D-0917-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0917-2017%22&limit=1).

Why it’s dangerous

The syringes contain confirmed mold, indicating a lack of sterility. Introducing non-sterile substances via subcutaneous injection can lead to serious infections or other adverse health reactions in patients.

Who’s affected

Patients in Florida who purchased or were prescribed Human Chorionic Gonadotropin (HCG) from Complete Pharmacy and Medical Solutions LLC are affected. Individuals using this medication for subcutaneous administration are at risk of infection due to the mold contamination.

How to tell if you have this one

Check if you have Human Chorionic Gonadotropin, 125 IU HCG, in a 0.5 ml syringe for subcutaneous administration. The recalled product is Rx only and has Lot # 2079ps5 with an expiration date of 02/01/2016.

  • Brand
    Complete Pharmacy & Medical Solutions
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the syringes

    Do not use any HCG syringes matching the recalled lot number due to mold contamination.

  2. Contact your healthcare provider

    Consult your doctor or pharmacist regarding alternative treatment options if you have used this product.

Where it went and when

Where it was distributed

Distributed in Florida.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: yesFL

FDA distribution: “Distributed throughout Florida” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Florida.

Recall timeline

FDA published this recall 18 months after the firm started it.

1. Firm started the recall: Dec 29, 201512. FDA classified it Class I: Jun 13, 201723. Published in FDA’s Enforcement Report: Jun 21, 2017320152017
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0917-2017 (December 29, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0917-2017 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA